Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

A protocol for an international, multicentre pharmacokinetic study for Screening Antifungal Exposure in Intensive Care Units: The SAFE-ICU study.

Autor: Roberts JA; University of Queensland Centre for Clinical Research, Faculty of Medicine, The University of Queensland, Brisbane, QLD, Australia.; Departments of Intensive Care Medicine and Pharmacy, Royal Brisbane & Women's Hospital, Brisbane, QLD, Australia.; Division of Anaesthesiology Critical Care Emergency and Pain Medicine, Nîmes University Hospital, University of Montpellier, Nîmes, France., Sime F; University of Queensland Centre for Clinical Research, Faculty of Medicine, The University of Queensland, Brisbane, QLD, Australia., Lipman J; University of Queensland Centre for Clinical Research, Faculty of Medicine, The University of Queensland, Brisbane, QLD, Australia.; Division of Anaesthesiology Critical Care Emergency and Pain Medicine, Nîmes University Hospital, University of Montpellier, Nîmes, France.; Jamieson Trauma Institute, Royal Brisbane & Women's Hospital, Brisbane, QLD, Australia., Hernández-Mitre MP; University of Queensland Centre for Clinical Research, Faculty of Medicine, The University of Queensland, Brisbane, QLD, Australia., Baptista JP; Department of Intensive Care, Centro Hospitalar e Universitário de Coimbra (CHUC), Coimbra, Portugal., Brüggemann RJ; Department of Pharmacy and Radboudumc Institute of Health Sciences, And Radboudumc/CWZ Center of Expertise in Mycology, Radboud University Medical Center, Nijmegen, the Netherlands., Darvall J; Department of Critical Care, The University of Melbourne, Melbourne, VIC, Australia.; Department of Intensive Care, Royal Melbourne Hospital, Melbourne, VIC, Australia., De Waele JJ; Department of Intensive Care Medicine, Ghent University Hospital, Ghent, Belgium.; Department of Internal Medicine and Pediatrics, Faculty of Medicine and Health Sciences, Ghent University, Ghent, Belgium., Dimopoulos G; 3rd Department of Critical Care, EVGENIDIO Hospital, Medical School, National and Kapodistrian University of Athens, Greece., Lefrant JY; Division of Anaesthesiology Critical Care Emergency and Pain Medicine, Nîmes University Hospital, University of Montpellier, Nîmes, France.; UR-UM103 IMAGINE, Univ Montpellier, Division of Anesthesia Critical Care, Pain and Emergency Medicine, Nîmes University Hospital, Montpellier, France., Mat Nor MB; Kulliyyah of Medicine, International Islamic University Malaysia, Kuantan Campus, Malaysia., Rello J; Division of Anaesthesiology Critical Care Emergency and Pain Medicine, Nîmes University Hospital, University of Montpellier, Nîmes, France.; Clinical Research in Pneumonia & Sepsis, Vall D'Hebron Institute of Research, Barcelona, Spain., Seoane L; Faculty of Medicine, The University of Queensland, New Orleans, LA, USA.; Intensive Care Unit, Ochsner Health System, New Orleans, LA, USA., Slavin MA; National Centre for Infections in Cancer and Department of Infectious Diseases, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia.; Victorian Infectious Diseases Service, Royal Melbourne Hospital, Melbourne, Victoria, Australia., Valkonen M; Intensive Care Medicine, Department of Perioperative, Intensive Care and Pain Medicine, University of Helsinki and Helsinki University Hospital, Finland., Venditti M; Department of Public Health and Infectious Diseases, University 'Sapienza' of Rome, Rome, Italy., Wong WT; Department of Anaesthesia and Intensive Care, The Chinese University of Hong Kong, Hong Kong, SAR, China., Zeitlinger M; Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria., Roger C; Division of Anaesthesiology Critical Care Emergency and Pain Medicine, Nîmes University Hospital, University of Montpellier, Nîmes, France.; UR-UM103 IMAGINE, Univ Montpellier, Division of Anesthesia Critical Care, Pain and Emergency Medicine, Nîmes University Hospital, Montpellier, France.

Publikováno v: Critical care and resuscitation : journal of the Australasian Academy of Critical Care Medicine [Crit Care Resusc] 2023 May 20; Vol. 25 (1), pp. 1-5. Date of Electronic Publication: 2023 May 20 (Print Publication: 2023).

Use of the Hollow-Fiber Infection Model to Measure the Effect of Combination Therapy of Septic Shock Exposures of Meropenem and Ciprofloxacin against Intermediate and Resistant Pseudomonas aeruginosa Clinical Isolates.

Autor: Karabasevic N; Medical Programme, Faculty of Medicine, Lund University, Lund, Sweden., Roberts JA; Centre for Translational Anti-infective Pharmacodynamics, School of Pharmacy, The University of Queenslandgrid.1003.2, Brisbane, Queensland, Australia.; The University of Queenslandgrid.1003.2 Centre for Clinical Research, Brisbane, Queensland, Australia.; Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia.; Division of Anaesthesiology Critical Care Emergency and Pain Medicine, Nîmes University Hospital, University of Montpellier, Nîmes, France., Stronach L; Centre for Translational Anti-infective Pharmacodynamics, School of Pharmacy, The University of Queenslandgrid.1003.2, Brisbane, Queensland, Australia., Naicker S; Centre for Translational Anti-infective Pharmacodynamics, School of Pharmacy, The University of Queenslandgrid.1003.2, Brisbane, Queensland, Australia.; The University of Queenslandgrid.1003.2 Centre for Clinical Research, Brisbane, Queensland, Australia., Wallis SC; The University of Queenslandgrid.1003.2 Centre for Clinical Research, Brisbane, Queensland, Australia., Sjövall F; Department of Intensive Care and Perioperative Medicine, Skane University Hospital, Malmö, Sweden.; Mitochondrial Medicine, Lund University, Lund, Sweden., Sime F; Centre for Translational Anti-infective Pharmacodynamics, School of Pharmacy, The University of Queenslandgrid.1003.2, Brisbane, Queensland, Australia.; The University of Queenslandgrid.1003.2 Centre for Clinical Research, Brisbane, Queensland, Australia.

Publikováno v: Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2022 May 17; Vol. 66 (5), pp. e0214021. Date of Electronic Publication: 2022 Apr 07.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.